271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details

臨床試験数 : 563 / 薬物数 : 372 - (DrugBank : 72) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 145

519 trials found

diseases per page:

Showing 1 to 10 of 519 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05155098 (ClinicalTrials.gov)	March 1, 2022	30/11/2021	2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness ...	2 Years Prospective Study to Collect Real-life Data On the Retention, Quality of Life, Effectiveness ...	Moderate to Severe Plaque Psoriasis;Psoriatic Arthritis;Ankylosing Spondylitis;Non-radiographic Axia ...	Other: secukinumab	Novartis Pharmaceuticals	NULL	Not yet recruiting	18 Years	80 Years	All	360		NULL
2	NCT05257174 (ClinicalTrials.gov)	March 2022	28/1/2022	The Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory Arthritis	A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Jing Si Herbal Tea L ...	Arthritis;Rheumatoid Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis;Fatigue	Dietary Supplement: Jing Si Herbal Tea LIQUID PACKETS;Dietary Supplement: Placebo	Buddhist Tzu Chi General Hospital	NULL	Not yet recruiting	20 Years	99 Years	All	150	N/A	Taiwan
3	NCT05164198 (ClinicalTrials.gov)	January 15, 2022	8/11/2021	Multicenter, Prospective Clinical Trial for Optimizing TNF Inhibitor Dose Adjustment in Ankylosing S ...	Multicenter, Prospective Clinical Trial for Optimizing TNF Inhibitor Dose Adjustment in Ankylosing S ...	Ankylosing Spondylitis;Axial Spondyloarthritis	Biological: Adalimumab and its biosimilars;Biological: Biological: Etanercept and its biosimilars;Bio ...	Hanyang University Seoul Hospital	Linical Korea	Not yet recruiting	18 Years	65 Years	All	448	Phase 4	NULL
4	NCT04924270 (ClinicalTrials.gov)	January 2022	7/6/2021	Safety and Efficacy of Faecal Microbiota Transplantation in Treatment-naïve Patients With Newly Diag ...	Safety and Clinical Efficacy Associated With Faecal Microbiota Transplantation Performed in Treatmen ...	Rheumatoid Arthritis;Reactive Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis;Gouty Arthritis;P ...	Biological: Faecal microbiota transplantation;Other: Placebo	Torkell Ellingsen	Region of Southern Denmark;University of Southern Denmark	Not yet recruiting	18 Years	70 Years	All	200	Phase 2	NULL
5	NCT05094128 (ClinicalTrials.gov)	November 22, 2021	20/10/2021	A Study to Assess Disease Activity in Adult Participants With Ankylosing Spondylitis Who Receive Upa ...	Effectiveness of Upadacitinib in Patients With Ankylosing Spondylitis Suffering From Typical Disease ...	Radiographic Axial Spondylarthritis (r-axSpA)	Drug: Upadacitinib	AbbVie	NULL	Recruiting	18 Years	N/A	All	352		Germany
6	NCT04876781 (ClinicalTrials.gov)	November 1, 2021	20/4/2021	Korean Post-marketing Surveillance for Xeljanz XR	Korean Post-marketing Surveillance for Xeljanz XR (Registered)	Active Moderate to Severe Rheumatoid Arthritis;Active Ankylosing Spondylitis	Drug: Tofacitinib XR	Pfizer	NULL	Not yet recruiting	18 Years	N/A	All	200		NULL
7	NCT04947579 (ClinicalTrials.gov)	August 25, 2021	23/6/2021	A Study of CC-99677 in Participants With Active Ankylosing Spondylitis	A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evalu ...	Spondylitis, Ankylosing	Drug: CC -99677;Other: Placebo	Celgene	NULL	Recruiting	18 Years	65 Years	All	256	Phase 2	United States;Canada;Czechia;Germany;Poland;Romania;Russian Federation;Spain;Turkey
8	EUCTR2020-004284-98-GR (EUCTR)	15/07/2021	05/04/2021	Secukinumab open label roll-over extension protocol	An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored S ...	Psoriatic Arthritis, Ankylosing Spondylitis, non-radiographic axial spondyloarthritis, Severe Chroni ...	Trade Name: Cosentyx Product Name: Secukinumab Product Code: AIN457 INN or Proposed INN: secukinumab Oth ...	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	628	Phase 4	United States;Czechia;Greece;Spain;Guatemala;Russian Federation;Colombia;India;Egypt;Mexico;Poland;B ...
9	EUCTR2019-004108-37-DE (EUCTR)	09/07/2021	18/02/2021	A study to determine how effective and safe the drug CC-99677 is for patients with active Ankylosing ...	A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evalu ...	Ankylosing Spondylitis MedDRA version: 20.0;Level: PT;Classification code 10002556;Term: Ankylosing ...	Product Code: CC -99677 60mg Capsule INN or Proposed INN: 146368 Other descriptive name: CC -99677 Product ...	Celgene Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	256	Phase 2	United States;Czechia;Canada;Spain;Poland;Romania;Turkey;Russian Federation;Germany
10	NCT04934059 (ClinicalTrials.gov)	July 1, 2021	8/6/2021	Efficacy and Safety of Yuxuebi Tablet in Treating Night Pain of Ankylosing Spondylitis (AS).	A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy ...	Ankylosing Spondylitis	Drug: Yuxuebi tablet;Drug: Placebo tablet	China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	NULL	Not yet recruiting	18 Years	65 Years	All	60	Phase 4	China

First Previous1 2 3 4 5…52Next Last